167
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Cholinergic agonists inhibit proliferation of human fibroblast-like synoviocytes and monocytic cell lines and reduce VEGF and MMPs expression by these cells

, , , , &
Pages 246-254 | Received 04 Dec 2019, Accepted 15 Mar 2020, Published online: 05 Apr 2020

References

  • Guo Q, Wang Y, Xu D, et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6(1):15.
  • Chen Y, Sun W, Gao R, et al. The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis. Rheumatology (Oxford). 2013;52(10):1739–1747.
  • Arshadi D, Nikbin B, Shakiba Y, et al. Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: association with gender, disease activity and anti-CCP antibody. Int Immunopharmacol. 2013;17(3):763–767.
  • Korb-Pap A, Bertrand J, Sherwood J, et al. Stable activation of fibroblasts in rheumatic arthritis-causes and consequences. Rheumatology (Oxford). 2016;55(2):ii64–ii7.
  • Azizi G, Boghozian R, Mirshafiey A. The potential role of angiogenic factors in rheumatoid arthritis. Int J Rheum Dis. 2014;17(4):369–383.
  • MacDonald IJ, Liu SC, Su CM, et al. Implications of angiogenesis involvement in arthritis. Int J Mol Sci. 2018;19(7):2012.
  • Elshabrawy HA, Chen Z, Volin MV, et al. The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis. 2015;18(4):433–448.
  • Lee YH, Bae SC. Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis. Z Rheumatol. 2018;77(3):240–248.
  • Zhou M, Qin S, Chu Y, et al. Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium. Int J Clin Exp Pathol. 2014;7(6):3048–3056.
  • Mellado M, Martínez-Muñoz L, Cascio G, et al. T cell migration in rheumatoid arthritis. Front Immunol. 2015;6:384.
  • Choi ST, Kim JH, Seok JY, et al. Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model. Clin Rheumatol. 2009;28(3):333–337.
  • Ganesan R, Rasool M. Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: current status and future directions. Int Rev Immunol. 2017;36(1):20–30.
  • Chen Z, Wang H, Xia Y, et al. Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol. 2018;201(8):2472–2482.
  • Zhang Y, Jiang J, Xie J, et al. Combined effects of tumor necrosis factor-α and interleukin-1β on lysyl oxidase and matrix metalloproteinase expression in human knee synovial fibroblasts in vitro. Exp Ther Med. 2017;14:5258–5266.
  • Xue M, McKelvey K, Shen K, et al. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation. Rheumatology (Oxford). 2014;53(12):2270–2279.
  • Martelli D, McKinley MJ, McAllen RM. The cholinergic anti-inflammatory pathway: a critical review. Auton Neurosci. 2014;182:65–69.
  • Olofsson PS, Rosas-Ballina M, Levine YA, et al. Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev. 2012;248(1):188–204.
  • Corrado A, Neve A, Maruotti N, et al. Bone effects of biologic drugs in rheumatoid arthritis. Clin Dev Immunol. 2013;2013:945945.
  • McAllen RM, Cook AD, Khiew HW, et al. The interface between cholinergic pathways and the immune system and its relevance to arthritis. Arthritis Res Ther. 2015;17(1):87.
  • Borovikova LV, Ivanova S, Nardi D, et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci. 2000;85(1–3):141–147.
  • Wu S, Luo H, Xiao X, et al. Attenuation of collagen induced arthritis via suppression on Th17 response by activating cholinergic anti-inflammatory pathway with nicotine. Eur J Pharmacol. 2014;735:97–104.
  • Yi L, Luo JF, Xie BB, et al. α7 Nicotinic acetylcholine receptor is a novel mediator of sinomenine anti-inflammation effect in macrophages stimulated by lipopolysaccharide. Shock. 2015;44(2):188–195.
  • Altawi R, Kadetoff D, Westman M, et al. A proposed mechanism for autonomic dysfunction in rheumatoid arthritis-reduced vagal activity related to high intrathechal IL-1 β levels. Ann Rheum Dis. 2012;71:A1–A93.
  • Plummer HK, 3rd, Dhar M, Schuller HM. Expression of the alpha7 nicotinic acetylcholine receptor in human lung cells. Respir Res. 2005;6(1):29.
  • Leblond A, Allanore Y, Avouac J. Targeting synovial neoangiogenesis in rheumatoid arthritis. Autoimmun Rev. 2017;16(6):594–601.
  • Lefevre S, Meier FM, Neumann E, et al. Role of synovial fibroblasts in rheumatoid arthritis. Curr Pharm Des. 2014;21(2):130–141.
  • Zhou Y, Zuo X, Li Y, et al. Nicotine inhibits tumor necrosis factor-alpha induced IL-6 and IL-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Rheumatol Int. 2012;32(1):97–104.
  • Yang L, Gong H, Wang Y, et al. Nicotine alters morphology and function of retinal pigment epithelial cells in mice. Toxicol Pathol. 2010;38(4):560–567.
  • Finckh A, Dehler S, Costenbader KH, et al. Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 2007;66(8):1066–1071.
  • van Maanen MA, Stoof SP, van der Zanden EP, et al. The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation. Arthritis Rheum. 2009;60(5):1272–1281.
  • Hashimoto T, Ichiki T, Watanabe A, et al. Stimulation of alpha7 nicotinic acetylcholine receptor by AR-R17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice. Vascul Pharmacol. 2014;61(2–3):49–55.
  • Snoek SA, Verstege MI, van der Zanden EP, et al. Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. Br J Pharmacol. 2010;160(2):322–333.
  • Alkhattabi N, Todd I, Negm O, et al. Tobacco smoke and nicotine suppress expression of activating signaling molecules in human dendritic cells. Toxicol Lett. 2018;299:40–46.
  • Cui WY, Zhao S, Polanowska-Grabowska R, et al. Identification and characterization of poly(I:C)-induced molecular responses attenuated by nicotine in mouse macrophages. Mol Pharmacol. 2013;83(1):61–72.
  • Rothbard JB, Rothbard JJ, Soares L, et al. Identification of a common immune regulatory pathway induced by small heat shock proteins, amyloid fibrils, and nicotine. Proc Natl Acad Sci USA. 2018;115(27):7081–7086.
  • Patton GW, Powell DA, Hakki A, et al. Nicotine modulation of cytokine induction by LPS-stimulated human monocytes and coronary artery endothelial cells. Int Immunopharmacol. 2006;6(1):26–35.
  • Kim MS, Lee J, So HS, et al. Gamma-interferon (IFN-gamma) augments apoptotic response to mistletoe lectin-II via upregulation of Fas/Fas L expression and caspase activation in human myeloid U937 cells. Immunopharmacol Immunotoxicol. 2001;23(1):55–66.
  • Alvaro-Gracia JM, Yu C, Zvaifler NJ, et al. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on fibroblast-like synoviocytes: paradoxical induction of IFN-gamma and TNF-alpha receptor expression. J Clin Immunol. 1993;13(3):212–218.
  • Asao H, Fu XY. Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation. J Biol Chem. 2000;275(2):867–874.
  • Proost P, Struyf S, Van Damme J, et al. Chemokine isoforms and processing in inflammation and immunity. J Autoimmun. 2017;85:45–57.
  • Leppert D, Lindberg RL, Kappos L, et al. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev. 2001;36(2–3):249–257.
  • Muri L, Leppert D, Grandgirard D, et al. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis. Cell Mol Life Sci. 2019;76(16):3097–3116.
  • Boziki M, Grigoriadis N. An update on the role of matrix metalloproteinases in the pathogenesis of multiple sclerosis. Med Chem. 2018;14(2):155–169.
  • Löffek S, Schilling O, Franzke CW. Series “matrix metalloproteinases in lung health and disease”: biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2011;38:191–208.
  • Yan C, Boyd DD. Regulation of matrix metalloproteinase gene expression. J Cell Physiol. 2007;211(1):19–26.
  • Roomi MW, Kalinovsky T, Rath M, et al. Cytokines, inducers and inhibitors modulate MMP-2 and MMP 9 secretion by human Fanconi anemia immortalized fibroblasts. Oncol Rep. 2017;37(3):1842–1848.
  • Zhou L, Yan C, Gieling RG, et al. Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1. BMC Immunol. 2009;10(1):15.
  • Ashman RB, Vijayan D, Wells CA. IL-12 and related cytokines: function and regulatory implications in Candida albicans infection. Clin Dev Immunol. 2011;2011:1–9.
  • Zhou M, Zhang Y, Ardans JA, et al. Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. J Biol Chem. 2003;278(46):45406–45413.
  • Mengshol JA, Mix KS, Brinckerhoff CE. Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull’s-eye or missing the mark? Arthritis Rheum. 2002;46(1):13–20.
  • Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11(1):529–543.
  • Ainola MM, Mandelin JA, Liljestrom MP, et al. Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta. Clin Exp Rheumatol. 2005;23(5):644–650.
  • Kim KS, Choi HM, Lee YA, et al. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int. 2011;31(4):543–547.
  • Hatta T, Sano H, Sakamoto N, et al. Nicotine reduced MMP-9 expression in the primary porcine tenocytes exposed to cyclic stretch. J Orthop Res. 2013;31(4):645–650.
  • Klettner AK, Doths J, Roider J. Nicotine reduces VEGF-secretion and phagocytotic activity in porcine RPE. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):33–38.
  • Zhen Y, Ruixing Y, Qi B, et al. Nicotine potentiates vascular endothelial growth factor expression in balloon-injured rabbit aortas. Growth Factors. 2008;26(5):284–292.
  • Zhao H, Wu L, Wang Y, et al. Nicotine promotes vascular endothelial growth factor secretion by human trophoblast cells under hypoxic conditions and improves the proliferation and tube formation capacity of human umbilical endothelial cells. Reprod Biomed Online. 2017;34(4):406–413.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.